AN ACT FOR THE ARKANSAS STATE UNIVERSITY - ARKANSAS BIOSCIENCES INSTITUTE APPROPRIATION FOR THE 2026-2027 FISCAL YEAR.
HB1067 is the fiscal year 2026-2027 appropriation act for the Arkansas State University - Arkansas Biosciences Institute. It sets the institute’s authorized staffing levels, including regular, academic, and research positions, and establishes maximum salary rates for each position category. The bill also appropriates funds for personal services and operating expenses, including regular salaries, extra help, matching costs, operating expenses, and capital outlay, for a total appropriation of $5,643,838.
The measure is a standard budget bill that provides the spending authority needed for the institute to operate during the fiscal year beginning July 1, 2026. It includes special language governing how appropriated funds may be transferred between line items, requiring approval from the Division of Higher Education, the Chief Fiscal Officer of the State, and the Legislative Council or Joint Budget Committee. It also contains provisions limiting the use of Tobacco Settlement funds, stating that state funds are not automatically committed to replace those funds if they are insufficient or expire, unless later authorized by the General Assembly and Governor.
HB1067 affects Arkansas budget law by authorizing state spending for the Arkansas Biosciences Institute and setting the legal limits for salaries, staffing, and operating expenditures for the 2026-2027 fiscal year. It operates as a temporary appropriations act rather than a permanent change to the Arkansas Code, and its special language controls fund transfers, compliance with fiscal laws, and the handling of Tobacco Settlement-supported positions. The bill became Act 56, meaning it took effect as enacted appropriations law for the covered fiscal year.
The bill appears to have been routine and broadly noncontroversial, consistent with a Joint Budget Committee appropriation measure. No committee transcript or recorded vote information was provided showing opposition or debate, and the bill advanced to become Act 56. The presence of an emergency clause suggests legislative agreement that the appropriation needed to take effect on July 1, 2026 to avoid disruption in agency operations.
The main potential points of contention in this type of bill are not about policy direction but about budget control and funding flexibility. The special language restricts transfers unless approved by executive and legislative fiscal authorities, which reflects legislative oversight concerns. Another possible issue is the reliance on Tobacco Settlement funds, since the bill expressly disclaims any commitment to replace those funds with state money if they become insufficient or expire, a provision that can affect employees and program continuity. No specific objections or named opponents were included in the available materials.